Spouses and partners should ask about early warning signs, how diagnosis is confirmed, treatment fit, disease stages, and where to get help. These questions shape timely care and planning for Alzheimer's disease, a progressive brain disorder that damages memory, thinking, and daily function. A partner often notices change first. Clear questions help you bring useful details to the visit, understand options, and plan for care needs and your own health.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What early changes should we report?
- How will doctors confirm the diagnosis?
- Could anti-amyloid treatment fit?
- What will each stage demand from us?
- How do we protect both partners?
What early changes should we report?
The Alzheimer's Association lists memory loss that disrupts daily life as an early sign, including forgetting recently learned information, forgetting dates, or asking the same questions repeatedly, as described in 10 early signs and symptoms. That pattern differs from typical age-related forgetting.
Your examples matter because frequency, change over time, and impact on bills, cooking, driving, or appointments guide next steps. Bring a short record to the appointment: Ask what else could explain the symptoms. Ask which records, test results, or family observations to bring to follow-up.
- repeated questions, missed dates, or lost steps in familiar tasks
- when the change started and whether it is getting worse
- medicines, sleep, mood, hearing, and recent illness or stress
- what help is already needed at home
How will doctors confirm the diagnosis?
The National Institute on Aging says doctors combine medical history, tests of memory, problem-solving, attention and language, plus CT, MRI or PET brain scans to support diagnosis or rule out other causes, explained in how Alzheimer's disease is diagnosed. No single office visit settles the answer. Ask what each test checks and when results will return.
Ask about reversible causes, other brain disorders, and next referrals. Ask whether a spinal fluid test, amyloid test, or specialist visit is needed. Write down the exact diagnosis term used, plus what it changes for treatment, safety, driving, work, and follow-up.
Could anti-amyloid treatment fit?
Partners should ask whether treatment aimed at beta-amyloid fits the diagnosis, stage, and test results. According to the Food and Drug Administration, Leqembi, lecanemab-irmb, moved to traditional approval on July 6, 2023 after a confirmatory trial verified clinical benefit for adults with Alzheimer's disease.
According to National Institute on Aging reporting, Kisunla, donanemab-azbt, was FDA-approved July 2, 2024 for early symptomatic disease, with treatment to start in mild cognitive impairment or mild dementia where trials studied it. The National Institute on Aging also cautions that lecanemab and donanemab target beta-amyloid to reduce plaques and only modestly slow decline in early Alzheimer's with confirmed amyloid, requiring careful monitoring and suiting only selected patients. Ask about amyloid confirmation, benefits, brain swelling or bleeding risks, visit and scan burden, other medicines, and what would stop treatment.
What will each stage demand from us?
The Alzheimer's Association classifies progression into early, middle and late stages, with memory, function and care demands increasing. Early treatment access and legal, financial and care planning are time-sensitive. Ask what stage fits now and what change should prompt a new call.
Use early visits to set powers of attorney, care wishes, driving rules, home safety, and respite plans. Ask for referrals to social work, nursing, therapy, day programs, and local caregiver education. Revisit the plan when wandering, incontinence, sleep disruption, agitation, weight loss, or falls appear.
How do we protect both partners?
Caregiving affects the caregiving partner's body and brain. According to a JAMA Network Open 2026 study reported by MedicalXpress, researchers followed nearly 1 million married adults in Taiwan's 1998-2022 health records and found a spouse's new dementia diagnosis raised the partner's dementia risk by about 74% in women and 69% in men. Ask your own clinician about sleep, blood pressure, mood, hearing, exercise, social contact, and cognitive concerns.
Keep support close before a crisis. The Alzheimer's Association operates a free 24/7 Helpline at 800-272-3900, available 365 days yearly with specialists and master's-level clinicians for care planning, crisis, education and referrals, listed in Alzheimer's Association helpline resources. Save the number in both phones and call for care planning, behavior changes, or caregiver strain.
You Might Also Like
- Public Input Shaping the 2026-2035 National Alzheimer’s Plan: Coverage, Cost, and Access Questions for Spouses and Partners
- APOE4 With a Family History of Alzheimer’s: Questions to Ask About Brain Health
- Leqembi IQLIK Injection Training for Alzheimer’s Caregivers: What to Verify About Access, Training, and Follow-Up
